PharmEasy buys 66% stake in Thyrocare2 min read . Updated: 26 Jun 2021, 05:24 AM IST
The Thyrocare stock surged 6.23% to ₹1,448.05 on BSE. The announcement was made after the end of trading in Mumbai
Online pharmacy PharmEasy’s parent will buy a 66.1% stake in diagnostic chain Thyrocare Technologies for ₹4,546 crore, in a sign that Indians are increasingly using mobile apps for their healthcare needs.
Select your Category